Beam Global to Release 2023 Operating Results, Conference Call Scheduled for April 17, 2024 at 4:30 p.m. ET
SAN DIEGO, Calif., April 16, 2024 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), (the “Company”), a leading provider of […]
SAN DIEGO, Calif., April 16, 2024 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), (the “Company”), a leading provider of […]
SAN FRANCISCO, April 16, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the closing of its underwritten public […]
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between […]
KANSAS CITY, Kan., April 16, 2024 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision […]
WILMINGTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the […]
COLMAR, Pa., April 16, 2024 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM) today announced the […]
SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services […]
GAAP net loss of $6.8 million for the quarter, compared with GAAP net loss of $6.0 million in the prior […]
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness […]
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — Mercer International (NASDAQ: MERC) will release its first quarter results for the […]